Form CORRESP - Correspondence:
SEC Accession No. 0001213900-14-006672
Filing Date
2014-09-16
Accepted
2014-09-16 08:43:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 117822
  Complete submission text file 0001213900-14-006672.txt   118792
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations